Holen Sie sich die Stockscreener-App
2.29
1.34%
-0.04
Schlusskurs vom Vortag:
$2.33
Offen:
$2.35
24-Stunden-Volumen:
112.06K
Relative Volume:
0.23
Marktkapitalisierung:
$67.80M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-30.15M
KGV:
-0.5725
EPS:
-4
Netto-Cashflow:
$-21.66M
1W Leistung:
-12.26%
1M Leistung:
-2.18%
6M Leistung:
-31.58%
1J Leistung:
-38.86%
1-Tages-Spanne:
$2.26
$2.38
1-Wochen-Bereich:
$2.26
$2.62
52-Wochen-Spanne:
$1.58
$6.01
Nrx Pharmaceuticals Inc Stock (NRXP) Company Profile
Firmenname
Nrx Pharmaceuticals Inc
Sektor
Branche
Telefon
484-254-6134
Adresse
1201 ORANGE STREET, WILMINGTON
Vergleichen Sie NRXP mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NRXP
Nrx Pharmaceuticals Inc
|
2.2903 | 68.98M | 0 | -30.15M | -21.66M | -4.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
472.00 | 119.17B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
810.42 | 84.19B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
408.64 | 52.77B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
812.45 | 48.98B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
176.41 | 36.31B | 447.02M | -1.18B | -906.14M | -6.1812 |
Nrx Pharmaceuticals Inc Stock (NRXP) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-08 | Eingeleitet | H.C. Wainwright | Buy |
| 2025-04-02 | Eingeleitet | BTIG Research | Buy |
Nrx Pharmaceuticals Inc Aktie (NRXP) Neueste Nachrichten
Will NRx Pharmaceuticals Inc. Equity Warrant stock rally after Fed decisionsAnalyst Upgrade & Verified Technical Signals - ulpravda.ru
Why NRx Pharmaceuticals Inc. Equity Warrant stock appeals to dividend seekersWeekly Investment Recap & Risk Managed Investment Strategies - ulpravda.ru
Market Recap: Is NRx Pharmaceuticals Inc. Equity Warrant stock in correction or buying zoneJuly 2025 Earnings & Safe Capital Allocation Plans - ulpravda.ru
Can NRx Pharmaceuticals Inc. stock beat market expectations this quarterWeekly Risk Report & Daily Chart Pattern Signal Reports - ulpravda.ru
Why NRx Pharmaceuticals Inc. Equity Warrant stock attracts global investorsLow Beta Stocks & Start Your Free Trading Journey Today - ulpravda.ru
A High-Stakes Alliance Aims to Standardize Mental Health Care at Scale - MyChesCo
Will NRx Pharmaceuticals Inc. Equity Warrant stock reach all time highs in 20252026 world cup usa national team semifinals star players set piece tactics odds analysis preview - ulpravda.ru
NRx Pharmaceuticals (NASDAQ: NRXP) Partners With neurocare Group AG To Build Nationwide Neuroplastic Care Network - Digital Journal
NRx Pharmaceuticals and neurocare group AG Announce Joint Offering of Neuroplastic Therapy Targeting Depression, PTSD, and Other Mental Health Afflictions - citybiz
About Us - FinancialContent
D. Boral Capital Reaffirms "Buy" Rating for NRx Pharmaceuticals (NASDAQ:NRXP) - MarketBeat
NRx Pharmaceuticals and neurocare Group AG Announce Joint Offering of Neuroplastic Therapy Targeting Depression, PTSD, and other mental health afflictions - Investing News Network
NRx and neurocare partner to create nationwide neuroplastic care network - Investing.com
NRx and neurocare partner to create nationwide neuroplastic care network By Investing.com - Investing.com Australia
NRx Pharmaceuticals (Nasdaq:NRXP) and neurocare Group AG Announce Joint Offering of Neuroplastic Therapy Targeting Depression, PTSD, and other mental health afflictions - The Manila Times
Ulta Beauty To Rally Around 16%? Here Are 10 Top Analyst Forecasts For Friday - Benzinga
Breakout Zone: Is NRx Pharmaceuticals Inc Equity Warrant stock in correction or buying zone2025 Growth vs Value & Safe Entry Trade Signal Reports - moha.gov.vn
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
NRx Pharmaceuticals Completes Debt Repayment, Ends 2025 Debt-Free - The Globe and Mail
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Short Interest Up 38.2% in December - MarketBeat
NRX Pharmaceuticals, Inc. Eliminates All Balance Sheet Debt - TradingView — Track All Markets
New to The Street's Prestigious Client NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Receives Notification of US Food and Drug Administration Approval of Suitability Petition for NRx's Proposed Strength of Preservative-Free Ketamine - Sentinel-Standard
NRx’s preservative-free ketamine reaches FDA review as company targets 2026 launch - MSN
New to The Street Broadcasts Nationwide Tonight on Bloomberg Television Featuring NeOnc ($NTHI), Metaterra Holdings Inc., CISO Global ($CISO), and NRx Pharmaceuticals ($NRXP) - Idaho Statesman
Earnings Update: Why hedge funds are buying NRx Pharmaceuticals Inc. stockPortfolio Update Summary & Risk Controlled Swing Trade Alerts - moha.gov.vn
NRX Pharmaceuticals Earnings Notes - Trefis
Bearish Setup: Will NRx Pharmaceuticals Inc. Equity Warrant stock outperform value stocksJuly 2025 Opening Moves & Daily Volume Surge Signals - moha.gov.vn
Is NRx Pharmaceuticals Inc. stock a top momentum play2025 Buyback Activity & Safe Capital Investment Plans - ulpravda.ru
Will NRx Pharmaceuticals Inc. stock pay special dividends2025 Retail Activity & Low Drawdown Momentum Ideas - Улправда
Published on: 2025-12-19 15:23:52 - DonanımHaber
Why NRx Pharmaceuticals Inc. Equity Warrant stock is a value investor pickWeekly Stock Summary & Risk Adjusted Buy/Sell Alerts - DonanımHaber
Can NRx Pharmaceuticals Inc. stock withstand economic slowdownWatch List & Technical Buy Zone Confirmations - DonanımHaber
Is NRx Pharmaceuticals Inc. stock a buy in volatile markets2025 Earnings Surprises & Real-Time Stock Price Movement Reports - Улправда
NRx Pharmaceuticals (NASDAQ: NRXP) Eliminates Balance Sheet Debt Through Anson Equity Conversion - Digital Journal
Why NRx Pharmaceuticals Inc. Equity Warrant stock could see breakout soonJuly 2025 Short Interest & Stepwise Trade Execution Plans - Улправда
What momentum indicators show for NRx Pharmaceuticals Inc. stockTrade Risk Summary & High Return Stock Watch Alerts - Улправда
NRx Pharmaceuticals clears remaining $5.4 million debt By Investing.com - Investing.com Nigeria
Can NRx Pharmaceuticals Inc. stock rebound after recent weakness2025 Breakouts & Breakdowns & High Accuracy Trade Signal Alerts - Улправда
NRx Pharmaceuticals Announces Elimination of All Balance Sheet Debt Following Equity Conversion - citybiz
NRx Pharmaceuticals announces elimination of all balance sheet debt following equity conversion - Investing News Network
NRx Pharmaceuticals clears remaining $5.4 million debt - Investing.com
NRx Pharmaceuticals Completes Repayment of $5.4 Million Debt, Positioning Company for Growth in 2026 - Quiver Quantitative
NRx Pharmaceuticals (Nasdaq:NRXP) announces elimination of all balance sheet debt following equity conversion - marketscreener.com
NRx Pharmaceuticals (NASDAQ:NRXP) Given Buy Rating at HC Wainwright - MarketBeat
NRXP: HC Wainwright & Co. Reiterates Buy Rating with $40 Target - GuruFocus
HC Wainwright & Co. Reiterates NRx Pharmaceuticals (NRXP) Buy Recommendation - Nasdaq
Market Outlook: Does NRx Pharmaceuticals Inc stock trade at a discount to peersJuly 2025 Drop Watch & Stock Timing and Entry Methods - moha.gov.vn
[S-3/A] NRX Pharmaceuticals, Inc. Amended Shelf Registration Statement | NRXP SEC FilingForm S-3/A - Stock Titan
NRx Eyes Faster Commercial Path as NRX-101 Moves Into TMS-Enhanced Depression Treatment - MyChesCo
NRx’s Preservative-Free Ketamine Reaches FDA Review as Company Targets 2026 Launch - MyChesCo
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Finanzdaten der Nrx Pharmaceuticals Inc-Aktie (NRXP)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.59%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):